Abstract
From the information overload that typifies the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)—and the September 2006 ICAAC in San Francisco met that standard—emerges a picture of shifting patterns for nosocomial infections and antibiotic resistance. Resistance development easily outpaces the appearance of new antimicrobial drugs, except perhaps in the case of fungal pathogens (see p. 7). This mis-match is a challenge that has some infectious disease experts urging novel policy strategies, such as establishing dedicated federal funding to support research on new antibiotics in an effort to reclaim momentum from the bacterial pathogens.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call